NUVECTIS PHARMA
Nuvectis Pharma is a bio-pharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer. Nuvectis is led by a management team comprised of industry veterans with broad and extensive drug development experience, and a proven track record of clinical and regulatory success. By leveraging our core competencies of target selection, drug profiling, and clinical and regulatory execution we are building our pipeline of product candidates for development in various oncology indications.
NUVECTIS PHARMA
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2020-01-01
Address:
Fort Lee, New Jersey, United States
Country:
United States
Website Url:
http://www.nuvectis.com
Status:
Active
Contact:
(201) 614-3151
Total Funding:
31.2 M USD
Technology used in webpage:
Mobile Non Scaleable Content ReCAPTCHA Google Google Cloud GoDaddy SSL Java EE Visa New Relic Google Cloud Global Multi-Region MasterCard
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Marius Pharmaceuticals
Marius Pharmaceuticals is a biopharmaceutical company that brings novel treatments to a range of diseases with unmet medical needs.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.nuvectis.com Semrush global rank: 5.49 M Semrush visits lastest month: 1.56 K
- Host name: box2455.bluehost.com
- IP address: 69.195.76.217
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Nuvectis Pharma"
Nuvectis Pharma, Inc.
We are a biopharmaceutical company focused on the development of novel targeted therapeutics for the treatment of cancer. We are developing NXP800, an oral small molecule inhibitor of the …See details»
About - Nuvectis Pharma, Inc.
Nuvectis pharma, inc. is a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical …See details»
Nuvectis Pharma - Crunchbase Company Profile & Funding
Nuvectis Pharma is a bio-pharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer. Nuvectis is led by a management team comprised of …See details»
Nuvectis Pharma - LinkedIn
Nuvectis Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical …See details»
Investors - Nuvectis Pharma, Inc.
Sep 14, 2023 · NXP800 demonstrated single agent activity New dosing schedule successfully minimized thrombocytopenia Fort Lee, NJ, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Nuvectis …See details»
Nuvectis Pharma, Inc - LinkedIn
Executive Vice President, Chief Scientific & Business Officer at Nuvectis Pharma, Inc. Shay Shemesh EVP, Chief Development & Operations Officer at Nuvectis Pharma, Inc.See details»
Nuvectis Pharma Company Profile - Office Locations, Competitors …
Oct 29, 2024 · Nuvectis Pharma (formerly known as Centry Pharma) is a biopharmaceutical company focused on precision medicines for cancer treatment. It develops NXP800, an …See details»
Nuvectis Pharma - Overview, News & Similar companies - ZoomInfo
Mar 21, 2024 · Nuvectis Pharma contact info: Phone number: (201) 614-3150 Website: www.nuvectis.com What does Nuvectis Pharma do? Founded in 2020, Nuvectis Pharma is a …See details»
Nuvectis Pharma, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Nuvectis Pharma, Inc. of Fort Lee, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Nuvectis Pharma, Inc. (NVCT) - Yahoo Finance
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology.See details»
Nuvectis Pharma, Inc. Reports Fiscal Year 2022 Financial
Mar 7, 2023 · Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical …See details»
Unveiling the Future of Precision Medicine: A Closer Look at …
Jun 25, 2024 · Among the companies leading this transformative journey is Nuvectis Pharma, a biopharmaceutical firm dedicated to developing precision medicines for serious conditions of …See details»
Nuvectis Pharma, Inc. Reports Fiscal Year 2021 Financial
Mar 22, 2022 · Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for serious conditions of unmet medical need in …See details»
Nuvectis Pharma,
ARID1a is the most frequently mutated SWI/SNF subunit with an estimated prevalence of 35% in endometrial carcinomas. Inactivation of ARID1b is highly prevalent in undifferentiated and …See details»
Nuvectis Pharma Announces Encouraging Preliminary Data from
Fort Lee, NJ, March 14, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) today announced preliminary data from the ongoing Phase 1b clinical trial of NXP800 in …See details»
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results …
FORT LEE, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on …See details»
Nuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results …
FORT LEE, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on …See details»
Nuvectis Pharma Raises $15 Million and In-Licenses Exclusive …
Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology.See details»
NVCT Stock Price Quote - Morningstar
Nov 20, 2024 · See the latest Nuvectis Pharma Inc stock price (NVCT:XNAS), related news, valuation, dividends and more to help you make your investing decisions.See details»
Nuvectis Pharma CEO Says Increased Dose Intensity Needed To …
Nov 14, 2024 · Nuvectis Pharma, Inc. (NASDAQ:NVCT) stock is trading lower after the company reported data from the Phase 1b study evaluating NXP800 in patients with platinum-resistant …See details»